HELIX, INC. for HELIX, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 14, 2022 | $36,520 | Replaced |
| 1st Quarter - Amendment (this page) | Aug 3, 2023 | $110,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to Genomic research and testing, pandemic preparedness, viral surveillance and sequencing COVID-19 and other respiratory pathogens. Issues relating to the regulation of Lab Developed Tests including the VALID Act, Issues and funding related to the COVID-19 Public Health Emergency, COVID-19 PCR testing, and viral sequencing of COVID-19.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Medical/Disease Research/Clinical Labs MED
General issues relating to genomic research and testing, COVID-19 testing and research, viral surveillance and sequencing. Regulation of lab developed tests VALID Act discussion drafts.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.